Dermapharm Expands Natural Offering With France's Arkopharma
Germany's Dermapharm will pay €450m to acquire herbal specialist Arkopharma to expand its footprint in Europe's consumer health market in countries such as France, Spain and Italy.
You may also be interested in...
Soaring inflation, skyrocketing energy prices and fragile supply chains were just some the challenges faced by Germany's Dermapharm during a first half in which group sales rose by 10%.
In this episode, HBW Insight talks to regulatory expert Mihai Inceu about the challenges of innovating in Europe’s thriving food supplements market. Senior regulatory affairs officer at consultancy firm JensonR+, Inceu highlights some of the issues companies face in putting new wellness products onto the European market, particularly if they want to make health claims for herbal ingredients, also known as botanicals. As well as giving good advice about how to avoid getting into trouble with regulators, Inceu also points to some of the latest trends in this dynamic consumer health space.
EU Business News: Dermapharm Gets Boost From Vitamin D; Sanofi Plans Turkish Launch; Krka Posts Sales RIse
A round-up of European consumer health business news: Dermapharm sees 2021 sales rise on the back of increased vitamin D demand; Sanofi plans to launch Enzymatica's ColdZyme in Turkey; and Slovenia's Krka posts rise in OTC sales.